CDC Morbidity & Mortality Weekly Report: Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices
September 16, 2025
September 16, 2025
ATLANTA, Georgia, Sept. 16 (TNSLrpt) -- The U.S. Department of Health and Human Services Centers for Disease Control and Prevention issued the following document as part of its Morbidity and Mortality Weekly Report (No. 32) on August 28, 2025, entitled "Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices -- United States, 2025.":
. . .
. . .